Uterine Fibroids Treatment Market By Drug Class (GnRH Agonists, GnRH Antagonists, Progestins, Oral Contraceptives, Antifibrinolytics, Others), By Type (Submucosal Fibroids, Intramural Fibroids, Subserosal Fibroids, Pedunculated Fibroids), By Treatment Type (Pharmacological Treatment, Minimally Invasive Procedures {Uterine Artery Embolization, Laparoscopic Myomectomy, Hysteroscopic Myomectomy}, Surgical Treatment {Hysterectomy, Abdominal Myomectomy}), and By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

Report Coverage:

By Drug Class

• GnRH Agonists
• GnRH Antagonists
• Progestins
• Oral Contraceptives
• Antifibrinolytics
• Others

By Type

• Submucosal Fibroids
• Intramural Fibroids
• Subserosal Fibroids
• Pedunculated Fibroids

By Treatment Type

• Pharmacological Treatment
• Minimally Invasive Procedures
  • Uterine Artery Embolization
  • Laparoscopic Myomectomy
  • Hysteroscopic Myomectomy
• Surgical Treatment
  • Hysterectomy
  • Abdominal Myomectomy

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• AbbVie Inc.
• Bayer AG
• Pfizer Inc.
• Myovant Sciences
• Gedeon Richter Plc
• AstraZeneca
• Novartis AG
• Johnson & Johnson
• Ferring Pharmaceuticals
• Amring Pharmaceuticals
• Watson Pharmaceuticals
• Takeda Pharmaceutical Company
• Green Cross Corporation
• Repros Therapeutics Inc.
• ObsEva SA